Efficacy of Preventing Relapse Evaluated by a Multicenter Randomized Double-Blind Placebo-Controlled Withdrawal Study of Escitalopram in Japanese Adolescents with Major Depressive Disorder-Reference-Cited by-同舟云学术

Efficacy of Preventing Relapse Evaluated by a Multicenter Randomized Double-Blind Placebo-Controlled Withdrawal Study of Escitalopram in Japanese Adolescents with Major Depressive Disorder

Published:2023-12-01 Issue:10 Volume:33 Page:418-427
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Saito Takuya¹,Takahashi Hidetoshi²,Tsujii Noa³,Sasaki Tsuyoshi⁴,Yamaguchi Yuta⁵,Takatsu Masahiro⁵,Sato Masaki⁵^ORCID

Affiliation:

1. Department of Child and Adolescent Psychiatry, Hokkaido University Hospital, Sapporo, Japan.

2. Kochi Medical School Department of Child and Adolescent Psychiatry, Kochi University, Kochi, Japan.

3. Department of Child Mental Health and Development, Toyama University Hospital, Toyama, Japan.

4. Department of Child Psychiatry, Chiba University Hospital, Chiba, Japan.

5. Mochida Pharmaceutical Co., LTD., Shinjuku-ku, Japan.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology and Child Health

Link

https://www.liebertpub.com/doi/pdf/10.1089/cap.2023.0048

Reference20 articles.

1. Diagnostic and Statistical Manual of Mental Disorders

2. Phenomenology of major depression from childhood through adulthood: analysis of three studies

3. 7.3 ADAPTING AND IMPLEMENTING SUPPORT FOR STUDENTS EXPOSED TO TRAUMA IN SOUTH KOREA: A PILOT STUDY

4. Fluoxetine Versus Placebo in Preventing Relapse of Major Depression in Children and Adolescents

5. Escitalopram in the Treatment of Adolescent Depression: A Randomized Placebo-Controlled Multisite Trial

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From the Editor-in-Chief’s Desk: Advancing Evidence-Based Treatments for Disruptive Mood Dysregulation Disorder;Journal of Child and Adolescent Psychopharmacology;2024-06-01